Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aldeyra Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ALDX
Nasdaq
2836
www.aldeyra.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aldeyra Therapeutics, Inc.
3 Stocks That May Be Undervalued By Up To 48.1% According To Intrinsic Value Estimates
- Apr 10th, 2026 11:38 am
3 Stocks Possibly Undervalued By Up To 47% Offering Potential Value
- Apr 10th, 2026 5:37 am
3 Stocks That May Be Trading Below Their Estimated Intrinsic Value
- Apr 9th, 2026 11:38 am
3 Stocks That May Be Undervalued In April 2026
- Apr 9th, 2026 5:37 am
Aldeyra Therapeutics And 2 More Promising Penny Stocks For Your Watchlist
- Mar 25th, 2026 12:05 pm
ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA
- Mar 18th, 2026 9:10 am
Aspen’s fresh Parkinson’s data; Aldeyra tanks following FDA rejection
- Mar 18th, 2026 5:45 am
FDA issues CRL to Aldeyra’s reproxalap drug application
- Mar 18th, 2026 4:18 am
Aldeyra Therapeutics Shares Fall Pre-Bell After US FDA Response Cites Lack of Efficacy Data for Dry Eye Drug
- Mar 17th, 2026 7:17 am
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
- Mar 17th, 2026 6:30 am
SSR Mining Stock Up 180% as New $5 Million Stake Signals Gold Conviction
- Mar 3rd, 2026 2:10 pm
Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy
- Mar 3rd, 2026 1:57 pm
Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?
- Feb 26th, 2026 7:40 am
Aldeyra Therapeutics CEO Highlights Reproxalap Ahead of March 16 FDA Decision at Oppenheimer Conference
- Feb 25th, 2026 1:29 pm
Does Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect?
- Feb 19th, 2026 7:55 am
Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Feb 18th, 2026 5:01 am
Wall Street Analysts Predict a 65.75% Upside in Aldeyra Therapeutics (ALDX): Here's What You Should Know
- Feb 3rd, 2026 7:55 am
Are Medical Stocks Lagging Aldeyra Therapeutics (ALDX) This Year?
- Feb 3rd, 2026 7:40 am
ATA Creativity Global Among 3 Promising Penny Stocks
- Jan 20th, 2026 5:05 am
Aldeyra Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist
- Dec 22nd, 2025 5:05 am
Scroll